These results show that presentation of OM-MOG to MOG-specific TCR on CD4+ T cells stimulates reduced proliferation, IL-2 and IL-2R production compared to MOG, features that are consistent with the induction of antigen-specific T cell anergy. The gene discussed is IL2; the disease is ocular melanoma.